The price of mesalamine can vary based on several factors, including the specific formulation, dosage, manufacturer, and pharmacy.
How much does a prescription for mesalamine typically cost?
For individuals paying out-of-pocket, the cost of mesalamine can range significantly. For instance, a 30-day supply of some mesalamine rectal suppositories might cost around \$400 to \$500 without insurance [1]. Oral mesalamine formulations, such as delayed-release capsules, can also be expensive, with a 30-day supply potentially costing upwards of \$200 to \$300 without insurance [1]. Prices can fluctuate, and discounts or coupons may be available.
Are there different types of mesalamine and do they affect the price?
Yes, mesalamine is available in various forms, including oral capsules, delayed-release tablets, extended-release capsules, and rectal suppositories or enemas. Each formulation is designed for different therapeutic needs and delivery methods, which can influence their pricing. For example, some extended-release oral formulations might have different price points than standard oral capsules or rectal preparations.
What is the average cost of mesalamine with insurance?
When mesalamine is covered by insurance, the patient's out-of-pocket cost is typically reduced to a copay or coinsurance amount. This cost is determined by the specific insurance plan, including the formulary tier the drug is placed on. Some plans may have lower copays for generic versions if available, or preferred brands. It is advisable to check with one's insurance provider for exact coverage details and estimated costs.
How can I find cheaper mesalamine options?
Patients may find lower prices for mesalamine by comparing costs at different pharmacies, using discount cards or coupons offered by manufacturers or third-party discount providers, and inquiring about generic alternatives if applicable [1]. Prescription savings programs and comparing prices through online pharmacies can also lead to cost reductions. Exploring patient assistance programs from the drug manufacturer might be an option for those who qualify based on income.
When did mesalamine patents expire?
The patent landscape for mesalamine is complex, with multiple patents covering different formulations and delivery methods. For instance, some extended-release formulations have patents that have expired or are nearing expiration. Information on specific patent expiration dates for various mesalamine products can be found on resources like DrugPatentWatch.com [2].
Who manufactures mesalamine and how does that affect price?
Several pharmaceutical companies manufacture mesalamine. The presence of multiple manufacturers, especially for generic versions, can increase competition and potentially lower prices. Brands like Apriso (developed by AbbVie) and Lialda (developed by Shire) are examples of specific mesalamine products. Generic versions are often produced by companies like Teva Pharmaceuticals and others.
What are the most common side effects patients experience with mesalamine?
Common side effects reported with mesalamine use include headache, nausea, diarrhea, abdominal pain, and cramping [3]. Some individuals may also experience rash, fever, or joint pain. It is important for patients to discuss any side effects with their healthcare provider.
How does mesalamine work to treat inflammatory bowel disease?
Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is an anti-inflammatory drug used to treat inflammatory bowel diseases like ulcerative colitis and proctitis. Its exact mechanism of action is not fully understood, but it is believed to work locally in the colon by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, and by scavenging reactive oxygen metabolites [3][4].
What are the alternatives to mesalamine for treating IBD?
Alternatives to mesalamine for managing inflammatory bowel disease include other aminosalicylates, corticosteroids (such as prednisone), immunomodulators (like azathioprine or methotrexate), and biologic therapies (such as infliximab or adalimumab) [4]. The choice of treatment depends on the severity and location of the disease, as well as individual patient factors.
Sources:
[1] https://www.goodrx.com/mesalamine
[2] https://drugpatentwatch.com/
[3] https://www.webmd.com/drugs/2/drug-7572/mesalamine-oral/details
[4] https://www.mayoclinic.org/drugs-supplements/mesalamine-oral-route-rectal-route/